Treated Cases News Today

DelveInsight's analysis estimates that the postherpetic neuralgia market is expected to show positive growth, mainly attributed to increased incidence and the anticipated launch of novel therapies

Currently, several emerging therapies, such as retifanlimab, BMX-001, LCB84, KEYTRUDA (pembrolizumab), and others, are being evaluated in late-stage and mid-stage clinical trials. The successful

/PRNewswire/ -- DelveInsights Usher Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, Usher syndrome...

/PRNewswire/ -- DelveInsights Giant-Cell Arteritis Market Insights report includes a comprehensive understanding of current treatment practices, giant-cell...

/PRNewswire/ -- DelveInsights Retinitis Pigmentosa Market Insights report includes a comprehensive understanding of current treatment practices, retinitis...

/PRNewswire/ -- DelveInsights Non-Postoperative Acute Pain Market Insights report includes a comprehensive understanding of current treatment practices,...

/PRNewswire/ -- DelveInsights Global mRNA-based Vaccines and Therapeutics Market Insights report includes a comprehensive understanding of current treatment...

/PRNewswire/ -- DelveInsights CAR T-Cell Therapy Market Insights report includes a comprehensive understanding of current treatment practices, emerging CAR...

/PRNewswire/ -- DelveInsights AAV Vectors in Gene Therapy Market Insights report includes a comprehensive understanding of current treatment practices,...

The growth of the metastatic castrate-resistant prostate cancer market is expected to be driven by the expected rising prevalence of prostate cancer cases due...